Astrea Amends $150M IPO Prospectus

Astrea Acquisition today filed an amended prospectus for its planned offer of 15 million units at $10 each. The raise remains unchanged from the $150 million listed in the SPAC’s initiasl filing earlier this month.

The amended filing includes the indemnifcation agreement for the SPAC’s executives and officers as well as an itemization of expenses related to the offer.

Astrea in its initial filing did not identify any particular industry or geographic region to target, noting only that it would focus on businesses with equity values greater than $350 million. 

The SPAC expects to trade on the Nasdaq under ASAXU. Read more.

Total
0
Shares
Related Posts
Read More

Perceptive Capital Solutions Files for $75M IPO

Perceptive Capital will focus on healthcare or healthcare-related industries. In particular, the company is targeting North American or European companies in the life sciences and medical technology sectors where management has extensive investment experience.